Thrombospondin promoted anti-tumor of adenovirus-mediated calreticulin in breast cancer: Relationship with anti-CD47

Biomed Pharmacother. 2015 Jul:73:109-15. doi: 10.1016/j.biopha.2015.05.017. Epub 2015 Jun 1.

Abstract

Objective: Calreticulin (CRT) protein has multifaceted role in carcinogenesis, however its role in breast cancer remains unidentified. In this study, we attempted to evaluate the effect of overexpressed CRT on breast cancer cells viability and proliferation.

Methods: Levels of mRNA and protein expression for CRT and CD47 in cells were determined by Quantitative RT-PCR analysis and Western blot, respectively. Cells apoptosis was evaluated using Annexin V-FITC assay with flow cytometry. Cell viability was assessed using MTT assay. Cell migration and autophagy were also evaluated.

Results: In breast cancer cells of MCF-7 and MDA-MB-231, both CRT and CD47 expression were enhanced, compared with that in normal breast cells of MCF-10A. Overexpression of CRT by MCF-7 and MDA-MB-231 cells transfected with significantly suppressed cell migration, viability as well as promote cell apoptosis while exerted no effected on cell autophagy. Interestingly, combining of thrombospondin (TSP) and overexpression of CRT significantly induced cell autophagy and inhibited tumor growth in MCF-7 cells xenograft. In result of chip assay, we observed that TSP treatment promoted interaction of TSP with CRT and CD47.

Conclusion: TSP promoted anti-tumor of adenovirus-mediated CRT via forming complexes with CRT and CD47 in breast cancer.

Keywords: Autophagy; CD47; Calreticulin; MCF-7; MDA-MB-231; Thrombospondin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae*
  • Animals
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism*
  • CD47 Antigen / biosynthesis*
  • Calreticulin / biosynthesis*
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Female
  • Humans
  • MCF-7 Cells
  • Mice
  • Mice, Inbred C57BL
  • Thrombospondins / pharmacology
  • Thrombospondins / therapeutic use*
  • Xenograft Model Antitumor Assays / methods

Substances

  • CALR protein, human
  • CD47 Antigen
  • CD47 protein, human
  • Calreticulin
  • Thrombospondins